Efficacy and Safety of Tocilizumab Treatment COVID-19 Patients: A Case-Control Study and Meta-Analysis.

Weijun JiangWeiwei LiQiuyue WuYing HanJing ZhangTao LuoYanju GuoYang YangPeiran ZhuXin-Yi Xia

Published in: Infectious diseases and therapy (2021)

Tocilizumab significantly decreased mortality in COVID-19 patients with no increased discharge, secondary infection risk, adverse events, and mechanical ventilation in a meta-analysis. Our data suggest that clinicians should pay attention to tocilizumab therapy as an effective and safe treatment for COVID-19 patients.

Keyphrases

mechanical ventilation
rheumatoid arthritis
sars cov
acute respiratory distress syndrome
stem cells
working memory
cardiovascular disease
electronic health record
big data
health insurance
replacement therapy
bone marrow
respiratory failure
smoking cessation